Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes

 Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes

Companies embark on evidence-based research effort to advance health care
outcomes

PR Newswire

LOUISVILLE, Ky. and INDIANAPOLIS, Aug. 29, 2013

LOUISVILLE, Ky. and INDIANAPOLIS, Aug. 29, 2013 /PRNewswire/ -- Humana Inc.
(NYSE: HUM), one of the nation's leading health and well-being companies, and
Eli Lilly and Company (NYSE: LLY), a leading, innovation-driven corporation,
today announced a joint research collaboration aimed at improving the health
care of their members and patients.

Under the partnership, the companies will utilize their expertise and
resources to identify and analyze data and information with a focus on
improving health care quality and outcomes. The partnership reflects a shared
commitment by both companies to address the challenges of improving quality of
care and reducing treatment costs in today's complex and changing health care
environment.

"Pairing Humana's clinical expertise and rich, de-identified patient data with
Lilly's history and experience across many disease states allows us to
maximize the potential benefits for patient care and savings," said William
Fleming, Pharm.D., President of Humana Pharmacy Solutions. "By leveraging our
collective capabilities, we can work to address the critical health care needs
facing our country."

Under the terms of the multi-year agreement, the companies will conduct a
range of studies related to various disease states. Study methodologies
include: impact of interventions on outcomes, adherence programs, disease
management and pharmacoeconomics.

The initial project is aimed at investigating patient characteristics
associated with increased health care costs in people with type 2 diabetes.
This retrospective analysis utilizes de-identified medical, pharmacy and
laboratory claims data, in addition to research algorithms focused on
exploring patient attitudes and behaviors. Future studies may use this
information to identify modifiable characteristics that can be targeted with
behavioral and other therapeutic interventions.

"We are pleased to partner with Humana on research that will help benefit
patients facing a variety of diseases, including diabetes," said Dara
Schuster, M.D., Medical Fellow, Lilly Diabetes. "Working together, we hope to
provide patients with insights and guidance that will help them tailor their
care to best match their individual needs."

Comprehensive Health Insights (CHI), a wholly owned subsidiary of Humana, will
serve as the research engine in the collaboration. Since 2008 CHI has
successfully partnered with a wide range of industry partners to perform
health economics and outcomes research using Humana's data assets.

About Humana
Humana Inc., headquartered in Louisville, Ky., is a leading health-care
company that offers a wide range of insurance products and health and wellness
services that incorporate an integrated approach to lifelong well-being. By
leveraging the strengths of its core businesses, Humana believes it can better
explore opportunities for existing and emerging adjacencies in health care
that can further enhance wellness opportunities for the millions of people
across the nation with whom the company has relationships.

More information regarding Humana is available to investors via the Investor
Relations page of the company's web site at www.humana.com, including copies
of:

  oAnnual reports to stockholders
  oSecurities and Exchange Commission filings
  oMost recent investor conference presentations
  oQuarterly earnings news releases
  oReplays of most recent earnings release conference calls
  oCalendar of events (including upcoming earnings conference call dates and
    times, as well as planned interaction with research analysts and
    institutional investors)
  oCorporate Governance information

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, IN, Lilly provides answers —
through medicines and information — for some of the world's most urgent
medical needs. Additional information about Lilly is available at
www.lilly.com.

C-LLY

FOR MORE INFORMATION, CONTACT:

Alex Kepnes
Humana Corporate Communications
502-580-2990
akepnes@humana.com 

Kelley Murphy
Eli Lilly and Company
317-701-4007
murphy_kelley@lilly.com

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

(Logo: http://photos.prnewswire.com/prnh/20130829/DE70165LOGO )

SOURCE Eli Lilly and Company; Humana Inc.

Website: http://www.lilly.com
Website: http://www.humana.com